Sarah Boyce Insider Trading $ISIS IONIS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah Boyce.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah Boyce. Sarah Boyce is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Chief Business Officer in IONIS PHARMACEUTICALS INC ($ISIS) and President and CEO in Avidity Biosciences, Inc. ($RNA) and President in AKCEA THERAPEUTICS, INC. ($AKCA) and Director in Berkeley Lights, Inc. ($BLI).
Sarah Boyce in IONIS PHARMACEUTICALS INC
Trading Symbol: ISISIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: Chief Business Officer
Holdings: 11,127 shares
Latest Transaction: Jan 17 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Sarah Boyce in IONIS PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKCA, RNA, BLI, ISIS, LGND
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 5,367 | 0 | 10,427 | |
Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 12,916 | 0 | 12,916 | |
Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 51.76 | 2,196 | 113,665 | 8,931 | 11.1 K to 8.9 K (-19.74 %) |
Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 5,367 | 0 | 11,127 | 5.8 K to 11.1 K (+93.18 %) |
Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 49.25 | 58,125 | 2,862,656 | 58,125 | |
Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 42.76 | 491 | 20,993 | 5,760 | 5.3 K to 5.8 K (+9.32 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 40.66 | 17 | 691 | 5,269 | 5.3 K to 5.3 K (+0.32 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 1,295 | 0 | 3,883 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,188 | 0 | 4,374 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 7,537 | 0 | 7,537 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 46.29 | 506 | 23,423 | 5,252 | 5.8 K to 5.3 K (-8.79 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 1,295 | 0 | 5,758 | 4.5 K to 5.8 K (+29.02 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 46.29 | 855 | 39,578 | 4,463 | 5.3 K to 4.5 K (-16.08 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 2,188 | 0 | 5,318 | 3.1 K to 5.3 K (+69.90 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 47.34 | 45,225 | 2,140,952 | 45,225 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 20.76 | 992 | 20,591 | 3,130 | 2.1 K to 3.1 K (+46.40 %) |
Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 20.76 | 403 | 8,365 | 2,138 | 1.7 K to 2.1 K (+23.23 %) |
Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,188 | 0 | 6,562 | |
Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 5,178 | 0 | 5,178 | |
Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Sell | S | 41.46 | 872 | 36,151 | 1,735 | 2.6 K to 1.7 K (-33.45 %) |
Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | M | 0.00 | 2,188 | 0 | 2,607 | 419 to 2.6 K (+522.20 %) |
Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 61.68 | 31,070 | 1,916,398 | 31,070 | |
Jan 04 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 47.71 | 419 | 19,991 | 419 | 0 to 419 |
Jan 20 2015 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 0.00 | 8,750 | 0 | 8,750 | |
Jan 05 2015 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 61.74 | 52,500 | 3,241,350 | 52,500 |
Page: 1